1999
DOI: 10.1002/jlb.66.1.83
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of cytokine-mediated β2-integrin activation on circulating neutrophils in critically ill patients

Abstract: The ␤ 2 integrin CD11b plays a central role in inflammation and the systemic inflammatory response syndrome (SIRS). The CD11b molecule activates in two ways: the density of membranebound CD11b up-regulates and the molecule undergoes a conformational change that confers adhesiveness to counter-receptors. We studied the kinetics of CD11b activation in patients with SIRS. We found a significantly diminished CD11b activation in response to tumor necrosis factor ␣ (TNF-␣). This affected all circulating polymorphonu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
25
3
2

Year Published

2001
2001
2021
2021

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(31 citation statements)
references
References 29 publications
1
25
3
2
Order By: Relevance
“…It is well known that several products of coagulation and fibrinolysis profoundly affect many facets of inflammatory reactions, such as induction of platelet activation (39), cytokine production by mononuclear phagocytes (40 -42), neutrophil aggregation, and chemotaxis (43- (9) recently reported selective activation of NF-B and AP-1 by physiological concentrations of soluble fibrinogen in PMA-differentiated U937 cells. Even more interesting, our results indicate that hFbg exerts its modulatory effect only on PMN previously primed by a purification procedure (34) or by TNF-␣ pretreatment (35). These results are in agreement with previous reports that show that ␤ 2 integrins are unable to interact with their physiological ligands in unstimulated leukocytes, a safety mechanism that controls acute and chronic inflammatory responses (6).…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…It is well known that several products of coagulation and fibrinolysis profoundly affect many facets of inflammatory reactions, such as induction of platelet activation (39), cytokine production by mononuclear phagocytes (40 -42), neutrophil aggregation, and chemotaxis (43- (9) recently reported selective activation of NF-B and AP-1 by physiological concentrations of soluble fibrinogen in PMA-differentiated U937 cells. Even more interesting, our results indicate that hFbg exerts its modulatory effect only on PMN previously primed by a purification procedure (34) or by TNF-␣ pretreatment (35). These results are in agreement with previous reports that show that ␤ 2 integrins are unable to interact with their physiological ligands in unstimulated leukocytes, a safety mechanism that controls acute and chronic inflammatory responses (6).…”
Section: Discussionsupporting
confidence: 92%
“…For activation parameters, we additionally demonstrate that hFbg induces the enhancement of CD11b and CD66b on the PMN surface. CD11b is up-regulated within minutes of exposure to proinflammatory substances such as TNF-␣, IL-8, C5a, leukotriene B 4 , and platelet-activating factor (35). However, like other integrins, CD11b must not only increase the expression on the cell, but it must undergo a qualitative change as well as bind to its counter-receptors (50).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…CD11b plays a central role in inflammation and in the systemic inflammatory response syndrome (18). Integrin belongs to a family of adhesion receptors and is found on the majority of cells in the body (19).…”
Section: Discussionmentioning
confidence: 99%
“…The downregulation of the CD11b response was present before and after TNF-· stimulation on lymphocytes, was present to a lesser extent on neutrophils, but was absent from monocytes, suggesting that different mechanisms of downregulation/control might exist for each cell type. The downregulation of CD11b expression on lymphocytes and neutrophils, when TNF-· is present in the serum, could offer a protective role against excess and damaging leucocyte activation, as can be seen in endotoxic shock [13] or in patients with systemic inflammatory response syndrome who have decreased CD11b activation on circulating leucocytes in response to TNF-· [14]. Conversely, an immune response which has been inappropriately 'damped down' may compromise host response and contribute to an increased risk of unrecognised and often fatal illness, often with a clinical scenario seen in very elderly subjects.…”
Section: Regression Analysis Of Tnf-· With Leucocyte Typementioning
confidence: 99%